# Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

> **NCT02624453** · NA · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 186 (actual)

## Conditions studied

- Cryptococcal Meningitis

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Antiretroviral therapy

## Key facts

- **NCT ID:** NCT02624453
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624453, "Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02624453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*